Salim Surani1* and Minahil Saleem2
1Clinical Professor, Texas A&M University, Texas USA
2MSIII Dow Medical College, Karachi, Pakistan
*Corresponding Author: Salim Surani, Clinical Professor, Texas A&M University, Texas USA.
Received: March 21, 2022; Published: March 30, 2022
The SARS-CoV2 or severe respiratory syndrome Cov2 or COVID-19, since its origin in the wet seafood market in Wuhan, China, in late 2019, has taken the world by storm affecting almost 467 million people globally, with 6,089,773 people being succumbed to this disease worldwide . In 2020, scientists focused on antiviral therapy, vaccines, and the role of repurposing medications. The vaccine came as a winner, hands down, with the Pfizer vaccine for COVID-19 making its way in late 2020. This was followed by several vaccines such as Moderna, AstraZeneca, Sinovac, Sputnik, Sinopharm, to name a few. As the vaccine supply was emerging, so was the disparity. In the initial phase, the developed country vaccination rate was far higher than the developing countries .
Citation: Salim Surani and Minahil Saleem. “COVID-19. Is it Still Pandemic or Endemic? What is its Future in 2022?”.Acta Scientific Medical Sciences 6.5 (2022): 01-03.
Copyright: © 2022 Salim Surani and Minahil Saleem. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.